Occlutech Holding AG (œ Occlutech ) announces today that Marianne Dicander Alexandersson, Mette-Marie Harild , Helena Levander and Michel Lussier have been elected to the Board of Directors of Occlutech. Marianne Dicander Alexandersson will be appointed Chair of the Board of Directors of Occlutech at the Annual General Meeting on June 18, 2021.
œWe are delighted to welcome Marianne, Mette-Marie, Helena and Michel to the Occlutech Board of Directors. Their collective management and industry experience will be invaluable to Occlutech so that we can continue our exciting adventure that will lead to the development of cutting-edge products, increase revenues and allow us to expand geographically, said Sabine Bois , Head of the management of Occlutech.
Tor Peters and Urs Christen were re-elected as members of the board of directors.
Marianne Dicander Alexandersson appointed President and elected to the Board of Directors
Marianne Dicander Alexandersson is a Swedish national and a consulting professional. She is currently president of Saminvest AB and Sahlgrenska Science Park AB and a member of the board of directors of Linc AB and Promore Pharma AB. She is also a member of the advisory board of TLV (The Swedish Dental and Pharmaceutical Agency).
Mette-Marie Harild elected to the board of directors
Mette-Marie Harild is a Danish national and a veteran of the medical device industry who has worked in the pharmaceutical / medical industry for over thirty years. She previously held sales and marketing positions at Rh´ne Poulenc and Janssen Pharma. She also served as Regional Vice President at Medtronic A / S in various regions for 13 years.
Helena Levander elected to the Board of Directors
Swedish national Helena Levander is a professional board member. She has 20 years of experience in banking and finance, as well as corporate governance and boards of directors in Sweden and Norway. She is a member of the board of directors of Stend¶rren Fastigheter, Rejlers, Concordia Maritime, Lannebo Fonder and Factoringgruppen.
Michel Lussier elected to the board of directors
Michel Lussier is a Canadian citizen and an experienced serial entrepreneur in the field of medical technologies and cell therapy. He is president of Celyad Oncology SA, iSTAR Medical SA and Gabi Smartcare SA. Previously, he spent 15 years at Medtronic Inc and 10 years at Volcano Corp where he served as Group President.
About Occlutech
Occlutech is a leading supplier of minimally invasive devices for structural heart disease. Occlutech develops, manufactures and markets products for structural heart disease and interatrial bypass to improve patient treatment. Occlutech has a large proven portfolio, with over 127,000 products sold, treating birth defects, stroke prevention and heart failure. Occlutech markets and sells its structural heart disease and atrial bypass products to hospitals and clinics in more than 80 countries through its direct sales service and international network of distribution partners. Occlutech has manufacturing and R&D sites in Jena, Germany, andIstanbul , Turkey, and an international customer service and supply center located in Helsingborg, Sweden.
Contact :
Sabine Bois
CEO of the Occlutech group
+49 160 90792130
sabine.bois@occlutech.com
Source URL - https://www.prnewswire.com/news-releases/nouveaux-membres-elus-au-conseil-d-administration-d-occlutech-846613044.html
